1. Home
  2. DDS vs RGEN Comparison

DDS vs RGEN Comparison

Compare DDS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dillard's Inc.

DDS

Dillard's Inc.

HOLD

Current Price

$643.43

Market Cap

9.5B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$147.55

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DDS
RGEN
Founded
1938
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DDS
RGEN
Price
$643.43
$147.55
Analyst Decision
Sell
Buy
Analyst Count
3
11
Target Price
$511.33
$177.18
AVG Volume (30 Days)
139.4K
668.8K
Earning Date
02-24-2026
02-19-2026
Dividend Yield
4.86%
N/A
EPS Growth
N/A
N/A
EPS
36.93
0.03
Revenue
$6,625,563,000.00
$707,890,000.00
Revenue This Year
$1.07
$17.86
Revenue Next Year
$0.57
$12.44
P/E Ratio
$17.37
$4,865.68
Revenue Growth
N/A
11.74
52 Week Low
$282.24
$102.97
52 Week High
$741.98
$175.77

Technical Indicators

Market Signals
Indicator
DDS
RGEN
Relative Strength Index (RSI) 50.05 31.59
Support Level $600.86 $145.01
Resistance Level $627.26 $160.88
Average True Range (ATR) 26.11 7.03
MACD -0.92 -2.05
Stochastic Oscillator 48.83 8.57

Price Performance

Historical Comparison
DDS
RGEN

About DDS Dillard's Inc.

Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: